Rani Therapeutics Holdings, Inc. (RANI) Revenue History
Annual and quarterly revenue from 2019 to 2024
Compound Annual Growth Rate (CAGR)
Loading revenue history...
RANI Revenue Growth
RANI Revenue Analysis (2019–2024)
As of May 8, 2026, Rani Therapeutics Holdings, Inc. (RANI) generated trailing twelve-month (TTM) revenue of $1.2 million. The most recent quarter (Q3 2025) recorded $0 in revenue.
Looking at the longer-term picture, RANI's 5-year compound annual growth rate (CAGR) stands at +1.0%, indicating moderate growth over time. The company achieved its highest annual revenue of $2.7 million in 2021.
When compared to Healthcare sector peers including LNTH (+0.6% YoY), ARQT (+95.3% YoY), and CDTX (-100.0% YoY). Compare RANI vs LNTH →
RANI Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| RANICurrent | $1M | - | +1.0% | -5186.2% | |
 LNTH | $1.5B | +0.6% | +35.3% | 20.2% | |
 ARQT | $376M | +95.3% | - | -3.3% | |
 CDTX | $1M | -100.0% | -42.9% | -13811.9% |
RANI Historical Revenue Data (2019–2024)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | $1.0M | - | $1.0M | 100.0% | $-53,314,000 | -5186.2% |
| 2023 | $0 | - | $-822,000 | - | $-66,099,000 | - |
| 2022 | $0 | -100.0% | $0 | - | $-63,451,000 | - |
| 2021 | $2.7M | +488.1% | $2.7M | 100.0% | $-51,599,000 | -1899.1% |
| 2020 | $462K | -52.8% | $462K | 100.0% | $-16,544,000 | -3581.0% |
| 2019 | $979K | - | $979K | 100.0% | $-27,065,000 | -2764.6% |
See RANI's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs RANI Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare RANI vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonRANI — Frequently Asked Questions
Quick answers to the most common questions about buying RANI stock.
Is RANI's revenue growth accelerating or slowing?
RANI TTM revenue: $1M. YoY growth: N/A. 5-year CAGR: +1.0%.
What is RANI's long-term revenue growth rate?
Rani Therapeutics Holdings, Inc.'s 5-year revenue CAGR of +1.0% reflects the variable expansion pattern. Current YoY growth of N/A is near this long-term average.
How is RANI's revenue distributed by segment?
RANI reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2019-2024 are available for download. Segment mix reveals concentration and diversification trends.